Comparative Efficacy of Cabozantinib and Ramucirumab After Sorafenib for Patients with Hepatocellular Carcinoma and Alpha-fetoprotein >= 400 ng/mL: A Matching-Adjusted Indirect Comparison

Trojan, J; Mollon, P; Daniele, B; Marteau, F; Martin, L; Li, YX; Xu, Q; Piscaglia, F; Zaucha, R; Sarker, D; Lim, HY; Venerito, M

Trojan, J (corresponding author), Goethe Univ Hosp Frankfurt, Gastrointestinal Oncol Unit, Med Clin 1, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.

ADVANCES IN THERAPY, 2021; 38 (5): 2472

Abstract

Introduction: Cabozantinib and ramucirumab are approved for the treatment of adults with hepatocellular carcinoma (HCC) following prior sorafenib trea......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索